Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kristina Steinmetz"'
Publikováno v:
Conservation Genetics Resources. 13:131-142
Conservation and management of protected species, particularly of elusive species such as pinnipeds, is hampered by knowledge gaps. In the case of studies using genetic data these are often attributed to a lack of representative samples. Therefore, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cd394cafdcc28da594ce633abb1b5e3
https://doi.org/10.1007/s12686-020-01182-4
https://doi.org/10.1007/s12686-020-01182-4
Autor:
Kristina Steinmetz, Lara Hakki, Fabian Unser-Nad, Julia Jacovides, Elise Baker, Eric Stover, Victoria Tang
Publikováno v:
Human Rights Quarterly. 42:594-622
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33240b9902ce35906fb2f4b3ec47beb9
https://doi.org/10.1353/hrq.2020.0034
https://doi.org/10.1353/hrq.2020.0034
Autor:
N. Haense, G.M. Haag, Claudia Pauligk, Michael A. Rieger, Salah-Eddin Al-Batran, Akin Atmaca, Frederik Marmé, Kristina Steinmetz, P. Ruf, Oliver G. Ottmann, Horst Lindhofer
Publikováno v:
BMC Cancer
Background: Ertumaxomab (ertu) is a bispecific, trifunctional antibody targeting Her2/neu, CD3 and the Fcγ-receptors I, IIa, and III forming a tri-cell complex between tumor cell, T cell and accessory cells. Methods: Patients (pts) with Her2/neu (1+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34df9a43168071c328e28ab6fc17ca99
http://europepmc.org/articles/PMC4937525
http://europepmc.org/articles/PMC4937525
Autor:
Hans-Michael Altmannsberger, Akin Atmaca, Salah-Eddin Al-Batran, Elke Jäger, Kristina Steinmetz, Claudia Pauligk
Publikováno v:
Oncology. 80:130-134
Background: This study was designed to investigate the expression of phosphorylated mitogen-activated protein kinase (p-MAPK/Erk1 and Erk2) and its correlation with outcomes in patients with metastatic gastric cancer. Methods: p-MAPK was detected by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81744971c982252a6bc53f38f8f18ff1
https://doi.org/10.1159/000329063
https://doi.org/10.1159/000329063
Autor:
Annett Maderer, Arno Schad, Nils Homann, Salah-Eddin Al-Batran, Ralf Hofheinz, Peter R. Galle, Claudia Pauligk, Harald Schmalenberg, Markus Moehler, Janis Kany, Kristina Steinmetz, Thomas Thomaidis
Publikováno v:
BMC Cancer
Background Combination of fluoropyrimidines and a platinum derivative are currently standards for systemic chemotherapy in advanced adenocarcinoma of the stomach and gastroesophageal junction (GEJ). Nevertheless, individual likelihood for response to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1200a56be9fd43da65071f4fc42050b
http://europepmc.org/articles/PMC4094395
http://europepmc.org/articles/PMC4094395
Autor:
Dominique Werner, Achim Battmann, Kristina Steinmetz, Tobin Jones, Salah-Eddin Al-Batran, Michele Martinez, Tiffany Lamb
Publikováno v:
Journal of Clinical Oncology. 32:19-19
19 Background: The evaluation of gene amplification and/or protein overexpression of HER2 in gastric cancer is a prerequisite to establish an adequate treatment strategy. Gastric tumors are heterogeneous and separate evaluations lead to uncertainties
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01572bc9bccbf2140c61f7b5a4d3b21b
https://doi.org/10.1200/jco.2014.32.3_suppl.19
https://doi.org/10.1200/jco.2014.32.3_suppl.19
Autor:
Tobin Jones, Salah-Eddin Al-Batran, Tiffany Lamb, Dominique Werner, Kristina Steinmetz, Michele Martinez, Achim Battmann
Publikováno v:
Journal of Clinical Oncology. 31:4100-4100
4100 Background: Amplification and/or protein overexpression of HER2 in gastric cancer is a prerequisite to establish an adequate treatment strategy. The European standard defined HER2 positivity by IHC as first evaluation assay followed by ISH in 2+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ca8e6a57918817a48624ad142326e4b
https://doi.org/10.1200/jco.2013.31.15_suppl.4100
https://doi.org/10.1200/jco.2013.31.15_suppl.4100
Autor:
Claudia Pauligk, Salah-Eddin Al-Batran, Havva Colak, Akin Atmaca, Kristina Steinmetz, Elke Jäger, Hans-Michael Altmannsberger, Dominique Werner
Publikováno v:
Journal of Clinical Oncology. 30:e14557-e14557
e14557 Background: The prognostic role of the epidermal growth factor receptor (EGFR) in metastatic gastric cancer has not been established. Methods: EGFR was analyzed by immunohistochemistry (IHC) in a total of 357 patients (formalin-fixed, paraffin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c71fcccbe8f854940103dbb652ad6e9
https://doi.org/10.1200/jco.2012.30.15_suppl.e14557
https://doi.org/10.1200/jco.2012.30.15_suppl.e14557
Autor:
R.D. Hofheinz, Hans-Michael Altmannsberger, Salah-Eddin Al-Batran, Elke Jaeger, Ralph M. Wirtz, C. Petry, Kristina Steinmetz, Claudia Pauligk, Akin Atmaca, Nils Homann
Publikováno v:
Journal of Clinical Oncology. 28:4017-4017
4017 Background: This study aimed at establishing MMP-9 mRNA expression as molecular prognostic factor for metastatic gastroesophageal cancer. Methods: Tumor samples from 3 prospective studies of t...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3cbfcc36495e808c9658cf3605353e0
https://doi.org/10.1200/jco.2010.28.15_suppl.4017
https://doi.org/10.1200/jco.2010.28.15_suppl.4017
Autor:
Salah-Eddin Al-Batran, Kristina Steinmetz, A. Pustowka, S. Janowski, Akin Atmaca, Claudia Pauligk, Elke Jaeger
Publikováno v:
Journal of Clinical Oncology. 28:e14531-e14531
e14531 Background: The mTOR pathway could be a potential target in the treatment of gastric cancer. This study was designed to determine the maximum-tolerated-dose and preliminary safety and effica...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1eff1bd4c8d71da494e82617df63b61e
https://doi.org/10.1200/jco.2010.28.15_suppl.e14531
https://doi.org/10.1200/jco.2010.28.15_suppl.e14531